BIOMATERIALS AND BIOSYSTEMS AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Editorial Board p.2 • Guide for Authors p.3 ISSN: 2666-5344 DESCRIPTION . Biomaterials and Biosystems is the newest title in Elsevier's biomaterials science portfolio; it sits alongside Biomaterials, Materials Today Bio and Materials Science and Engineering C: Materials for Biological Applications. As part of the broader Materials Today family, Biomaterials and Biosystems offers authors rigorous peer review, rapid decisions, and high visibility. Biomaterials and Biosystems is an interdisciplinary open access journal that publishes work at the nexus of engineering, chemistry, biology and medicine. The Journal covers the full spectrum of research, technology development and clinical translation of the biomedical engineering discipline. The Journal will effectively disseminate new knowledge, technologies, tools and discoveries in the field of human health and/or healthcare to the scientific community and to the wider community. The Journal commits to adhere to strict confidentiality agreements and affirms commitment to integrity and ethical conduct of the highest standard. Biomaterials and Biosystems selectively publishes manuscripts that: Deal with the development, assessment and application of the next generation of functional implantable devices that aspire to treat, augment or replace diseased and / or injured tissues, organs or functions of the body with their therapeutic capacity; Develop, assess and prove function of the next generation of biological systems that enable disease prevention, diagnosis, progression, monitoring, mitigation and treatment; and Discuss ethical and social implications of educational, scientific, technological and clinical developments in the applied field of biomedical engineering. Indicative example of specific topics covered by Biomaterials and Biosystems include:Advanced Therapy Medicinal Products; Artificial Organs; Bioadhesives; Bioceramics; Bioelectronics; Bioengineering; Biofabrication; Biomechanics; Biomedical Engineering; Bionics; Biopolymers; Biosensors; Biotechnology; Cardiovascular Engineering; Cell Delivery; Cell Engineering; Clinical Trials; Developmental Engineering; Diagnostics; Differentiated Cells; Drug Delivery; Extracellular Matrix; Functionalised Biomaterials; Gene Delivery; Growth Factor Delivery; Hard Tissue Engineering; Hybrid Biomaterials; Imaging; Implants; Immune Response; Immunoengineering; In vitro models; In vivo models; Interfaces; Lab-on-Chip; Mechanobiology; Medical Devices; Modular Biomaterials; Molecular Engineering; Nanobiomaterials; Nanomedicine; Neural Engineering; Ophthalmic; Organ-on-Chip; Orthopaedics; Pluripotent Stem Cells; Regenerative Medicine; Self-assembly; Skeletal Engineering; Soft Tissue Engineering; Stem Cells; Synthetic Biology; Synthetic Polymers; Systems Biology; Tissue Engineering; Translational Medicine; Vaccines; Wound Healing AUTHOR INFORMATION PACK 26 Sep 2021 www.elsevier.com/locate/bbiosy 1 The journal accepts the following article types: A Research Communication manuscript will be hypothesis-driven and will have a maximum of 5 display items (figures and tables). A Research Note manuscript will be hypothesis driven and will have a maximum of 3 display items (figures and tables). A Progress Report manuscript will have a maximum of 4 display items (figures and tables), will be of maximum of 6,000 words and will provide a critical view / perspective of the subject in hand of the last 10 years. A Review manuscript will have a maximum of 8 display items (figures and tables), will be of maximum of 12,000 words, will provide a comprehensive literature review of the subject in hand and will be educational in nature. We look forward to receiving your submissions! EDITORIAL BOARD . Editor-in-Chief Dimitrios Zeugolis, University College Dublin, Dublin, Ireland Editorial Board Members Aldo R. Boccaccini, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany Biomaterials, Tissue engineering, Bioceramics and bioactive glasses, Composite materials. Maria Farsari, Foundation of Research and Technology Hellas Library, Irakleio, Greece Multiphoton lithography, 3D printing, Laser fabrication Manuela E. Gomes, University of Minho, Braga, Portugal Deok-Ho Kim, Johns Hopkins University Department of Biomedical Engineering, Baltimore, Maryland, United States of America Biomaterials, Stem cell engineering, Tissue engineering, Organs-on-chips, Mechanobiology, Nanobiotechnology Sang Jin Lee, Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States of America biomaterials, tissue engineering, regenerative medicine, 3D bioprinting, electrospinning, in vitro tissue models, stem cells, biodegradable polymers, in situ tissue regeneration, vascular grafts, stem cell homing Sander Leeuwenburgh, Radboud University, Nijmegen, Netherlands João Mano, University of Aveiro Chemistry Department, Aveiro, Portugal Areas of expertise include: bio-inspired materials; cell and Tissue Engineering; nano/micro platforms for biomedicine Lorenzo Moroni, Maastricht University Institute for Technology-Inspired Regenerative Medicine, Maastricht, Netherlands Areas of expertise: biofabrication, biomaterials, regenerative medicine, stem cells Ralph Mueller, ETH Zurich, Zurich, Switzerland Fergal O'Brien, Royal College of Surgeons in Ireland Department of Anatomy, Dublin, Ireland Areas of expertise: biomaterials, drug delivery, nanomedicine, collagen, 3D printing Milica Radisic, University of Toronto, Toronto, Ontario, Canada Marina Rubert, ETH Zurich, Zurich, Switzerland Prasad Shastri, University of Freiburg, Freiburg im Breisgau, Germany Hasan Uludag, University of Alberta, Edmonton, Alberta, Canada gene delivery, non-viral carriers, RNAi Sandra Van Vlierberghe, Ghent University, Gent, Belgium Carsten Werner, TU Dresden, Dresden, Germany AUTHOR INFORMATION PACK 26 Sep 2021 www.elsevier.com/locate/bbiosy 2 GUIDE FOR AUTHORS . INTRODUCTION Article types: The journal accepts the following article types: A Research Communication manuscript will be hypothesis-driven and will have a maximum of 5 display items (figures and tables). A Research Note manuscript will be hypothesis driven and will have a maximum of 3 display items (figures and tables). A Progress Report manuscript will have a maximum of 4 display items (figures and tables), will be of maximum of 6,000 words and will provide a critical view / perspective of the subject in hand of the last 10 years. A Review manuscript will have a maximum of 8 display items (figures and tables), will be of maximum of 12,000 words, will provide a comprehensive literature review of the subject in hand and will be educational in nature. Submission checklist You can use this list to carry out a final check of your submission before you send it to the journal for review. Please check the relevant section in this Guide for Authors for more details. Ensure that the following items are present: One author has been designated as the corresponding author with contact details: • E-mail address • Full postal address All necessary files have been uploaded: Manuscript: • Include keywords • All figures (include relevant captions) • All tables (including titles, description, footnotes) • Ensure all figure and table citations in the text match the files provided • Indicate clearly if color should be used for any figures in print Graphical Abstracts / Highlights files (where applicable) Supplemental files (where applicable) Further considerations • Manuscript has been 'spell checked' and 'grammar checked' • All references mentioned in the Reference List are cited in the text, and vice versa • Permission has been obtained for use of copyrighted material from other sources (including the Internet) • A competing interests statement is provided, even if the authors have no competing interests to declare • Journal policies detailed in this guide have been reviewed • Referee suggestions and contact details provided, based on journal requirements For further information, visit our Support Center. BEFORE YOU BEGIN Ethics in publishing Please see our information on Ethics in publishing. Declaration of interest All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places: 1. A summary declaration of interest statement in the title page file (if double anonymized) or the manuscript file (if single anonymized). If there are no interests to declare then please state this: 'Declarations of interest: none'. 2. Detailed disclosures as part of a separate Declaration of Interest form, which forms part of the journal's official records. It is important for potential interests to be declared in both places and that the information matches. More information. AUTHOR INFORMATION PACK 26 Sep 2021 www.elsevier.com/locate/bbiosy 3 Submission declaration and verification Submission of an article implies that the work described has not been published previously (except in the form of an abstract, a published lecture or academic thesis, see 'Multiple, redundant or concurrent publication' for more information), that it is not under consideration for publication elsewhere, that its publication is approved by all authors